$125MSeries B, 24 June 2025
Funds the ORYOM platform and first-in-human clinical trials.
- Amount
- $125M
- Stage
- Series B
- Announced
- 24 June 2025
- Lead
- Eclipse
- Other investors
- Adani Group, Reiya Ventures, Fred Moll
- Use of funds
- Funds the ORYOM platform and first-in-human clinical trials.
- Checked
- Announced by the company
- Sources
- ForSight Robotics Secures $125M in Series B Funding, Addressing Global Surgeon Shortage and Exploding Demand f pulse2.com
ForSight Robotics Secures $125M in Series B Funding, Addressing Global Surgeon Shortage and Exploding Demand f businesswire.com